ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1844

$924K Total Retail Price of All Prescriptions

Rank: 68 out of 1844

493 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 14,796 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 658 578 1 1
OMEPRAZOLE 581 544 2 5
HYDROCODONE-ACETAMINOPHEN 479 427 S3 3 2
LISINOPRIL 469 376 4 4
SIMVASTATIN 453 383 5 3
NAMENDA 426 423 6 33
POTASSIUM CHLORIDE 393 369 7 16
DONEPEZIL HCL 374 374 8 26
METOPROLOL TARTRATE 342 308 9 11
AMLODIPINE BESYLATE 310 296 10 6
FUROSEMIDE 305 251 11 7
PRAVASTATIN SODIUM 301 266 12 10
ATENOLOL 267 210 13 17
CIPROFLOXACIN HCL 241 229 14 62
SERTRALINE HCL 228 224 15 21
TORSEMIDE 226 211 16 118
FAMOTIDINE 224 193 17 63
METFORMIN HCL 223 198 18 8
CITALOPRAM HBR 221 206 19 19
ALLOPURINOL 215 202 20 29
POLYETHYLENE GLYCOL 3350 202 158 21 39
GABAPENTIN 187 174 22 15
WARFARIN SODIUM 179 172 23 13
FENTANYL 170 169 S2 24 66
METOPROLOL SUCCINATE 157 152 25 14
HYDROCHLOROTHIAZIDE 155 150 26 9
TAMSULOSIN HCL 151 142 27 27
TRAMADOL HCL 142 129 28 18
LOSARTAN POTASSIUM 135 135 29 24
LOVASTATIN 134 112 30 44
CLOPIDOGREL 134 118 30 34
CHLORTHALIDONE 131 107 32 176
LANTUS 126 110 33 42
ATORVASTATIN CALCIUM 125 111 34 12
METFORMIN HCL ER 122 118 35 46
CRESTOR 122 102 35 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 99 37 20
FLUTICASONE PROPIONATE 117 89 38 50
DIGOXIN 113 95 39 67
ZOLPIDEM TARTRATE 104 93 40 23
DIVALPROEX SODIUM 104 94 40 74
ALBUTEROL SULFATE 103 80 42 115
GLIPIZIDE 102 102 43 70
SPIRONOLACTONE 102 71 43 60
ALENDRONATE SODIUM 100 89 45 25
CLONIDINE HCL 99 72 46 64
GLIMEPIRIDE 95 82 47 35
RISPERIDONE 92 92 48 65
FLUOXETINE HCL 88 80 49 41
PREDNISONE 88 87 49 40
MIRTAZAPINE 87 85 51 49
ESCITALOPRAM OXALATE 84 65 52 52
PLAVIX 84 70 52 61
ISOSORBIDE MONONITRATE ER 82 77 54 59
CARVEDILOL 82 64 54 22
PANTOPRAZOLE SODIUM 81 65 56 32
HYDRALAZINE HCL 80 46 57 120
LEVOFLOXACIN 78 74 58 78
TRAZODONE HCL 75 55 59 43
RANITIDINE HCL 75 55 59 38
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 61 47
TAMIFLU 74 68 61 296
CEPHALEXIN 73 56 63 56
ADVAIR DISKUS 70 65 64 51
HUMALOG 68 50 65 114
CYMBALTA 66 60 66 36
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 64 67 99
TERAZOSIN HCL 63 51 68 136
SPIRIVA 63 49 68 57
BACLOFEN 63 42 68 119
TRICOR 60 44 71 109
SYNTHROID 58 58 72 55
PROAIR HFA 56 35 73 45
NOVOLOG 55 30 74 84
QUETIAPINE FUMARATE 55 54 74 82
ENOXAPARIN SODIUM 54 54 76 240
LYRICA 52 28 77 92
DOXAZOSIN MESYLATE 52 38 77 110
FINASTERIDE 52 39 77 137
LACTULOSE 52 40 77 171
GLIPIZIDE ER 51 32 81 79
GEMFIBROZIL 51 39 81 108
AMOX TR-POTASSIUM CLAVULANATE 51 41 81 139
LEVEMIR 50 46 84 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.